208 related articles for article (PubMed ID: 2140065)
1. Microangiopathy and the colocalization of heparan sulfate proteoglycan with amyloid in senile plaques of Alzheimer's disease.
Perlmutter LS; Chui HC; Saperia D; Athanikar J
Brain Res; 1990 Jan; 508(1):13-9. PubMed ID: 2140065
[TBL] [Abstract][Full Text] [Related]
2. Association between vascular basement membrane components and the lesions of Alzheimer's disease.
Perlmutter LS; Barrón E; Saperia D; Chui HC
J Neurosci Res; 1991 Dec; 30(4):673-81. PubMed ID: 1787541
[TBL] [Abstract][Full Text] [Related]
3. Heparan sulfate proteoglycan in diffuse plaques of hippocampus but not of cerebellum in Alzheimer's disease brain.
Snow AD; Sekiguchi RT; Nochlin D; Kalaria RN; Kimata K
Am J Pathol; 1994 Feb; 144(2):337-47. PubMed ID: 8311117
[TBL] [Abstract][Full Text] [Related]
4. Heparan sulfate proteoglycan expression in cerebrovascular amyloid beta deposits in Alzheimer's disease and hereditary cerebral hemorrhage with amyloidosis (Dutch) brains.
van Horssen J; Otte-Höller I; David G; Maat-Schieman ML; van den Heuvel LP; Wesseling P; de Waal RM; Verbeek MM
Acta Neuropathol; 2001 Dec; 102(6):604-14. PubMed ID: 11761721
[TBL] [Abstract][Full Text] [Related]
5. Localization of heparan sulfate glycosaminoglycan and proteoglycan core protein in aged brain and Alzheimer's disease.
Su JH; Cummings BJ; Cotman CW
Neuroscience; 1992 Dec; 51(4):801-13. PubMed ID: 1488123
[TBL] [Abstract][Full Text] [Related]
6. Interaction between beta-amyloid protein and heparan sulfate proteoglycans from the cerebral capillary basement membrane in Alzheimer's disease.
Shimizu H; Ghazizadeh M; Sato S; Oguro T; Kawanami O
J Clin Neurosci; 2009 Feb; 16(2):277-82. PubMed ID: 19091577
[TBL] [Abstract][Full Text] [Related]
7. Microangiopathy, the vascular basement membrane and Alzheimer's disease: a review.
Perlmutter LS; Chui HC
Brain Res Bull; 1990 May; 24(5):677-86. PubMed ID: 2192775
[TBL] [Abstract][Full Text] [Related]
8. Pathological alterations of the cerebral microvasculature in Alzheimer's disease and related dementing disorders.
Buée L; Hof PR; Bouras C; Delacourte A; Perl DP; Morrison JH; Fillit HM
Acta Neuropathol; 1994; 87(5):469-80. PubMed ID: 8059599
[TBL] [Abstract][Full Text] [Related]
9. Binding of vascular heparan sulfate proteoglycan to Alzheimer's amyloid precursor protein is mediated in part by the N-terminal region of A4 peptide.
Buée L; Ding W; Anderson JP; Narindrasorasak S; Kisilevsky R; Boyle NJ; Robakis NK; Delacourte A; Greenberg B; Fillit HM
Brain Res; 1993 Nov; 627(2):199-204. PubMed ID: 8298962
[TBL] [Abstract][Full Text] [Related]
10. Amyloid beta protein precursor is possibly a heparan sulfate proteoglycan core protein.
Schubert D; Schroeder R; LaCorbiere M; Saitoh T; Cole G
Science; 1988 Jul; 241(4862):223-6. PubMed ID: 2968652
[TBL] [Abstract][Full Text] [Related]
11. Immunogold localization of basal laminar heparan sulfate proteoglycan in rat brain and retinal capillaries.
Lin WL
Brain Res Bull; 1990 Mar; 24(3):533-6. PubMed ID: 2140068
[TBL] [Abstract][Full Text] [Related]
12. Association of heparan sulfate proteoglycan with the neurofibrillary tangles of Alzheimer's disease.
Perry G; Siedlak SL; Richey P; Kawai M; Cras P; Kalaria RN; Galloway PG; Scardina JM; Cordell B; Greenberg BD
J Neurosci; 1991 Nov; 11(11):3679-83. PubMed ID: 1941102
[TBL] [Abstract][Full Text] [Related]
13. What role(s) may extracellular matrix, particularly heparan sulfate, play in amyloid of Alzheimer's disease.
Benditt EP
Neurobiol Aging; 1989; 10(5):506; discussion 510-2. PubMed ID: 2530463
[TBL] [Abstract][Full Text] [Related]
14. Heterogeneous distribution of a basement membrane heparan sulfate proteoglycan in rat tissues.
Couchman JR
J Cell Biol; 1987 Oct; 105(4):1901-16. PubMed ID: 2959669
[TBL] [Abstract][Full Text] [Related]
15. Agrin is a major heparan sulfate proteoglycan accumulating in Alzheimer's disease brain.
Verbeek MM; Otte-Höller I; van den Born J; van den Heuvel LP; David G; Wesseling P; de Waal RM
Am J Pathol; 1999 Dec; 155(6):2115-25. PubMed ID: 10595940
[TBL] [Abstract][Full Text] [Related]
16. Identification in immunolocalization of a new class of proteoglycan (keratan sulfate) to the neuritic plaques of Alzheimer's disease.
Snow AD; Nochlin D; Sekiguichi R; Carlson SS
Exp Neurol; 1996 Apr; 138(2):305-17. PubMed ID: 8620929
[TBL] [Abstract][Full Text] [Related]
17. Abeta(1-40) prevents heparanase-catalyzed degradation of heparan sulfate glycosaminoglycans and proteoglycans in vitro. A role for heparan sulfate proteoglycan turnover in Alzheimer's disease.
Bame KJ; Danda J; Hassall A; Tumova S
J Biol Chem; 1997 Jul; 272(27):17005-11. PubMed ID: 9202014
[TBL] [Abstract][Full Text] [Related]
18. [Proteoglycans in senile dementia of Alzheimer's type].
Shimizu H; Sato S; Ohishi H; Mori O; Mori T; Ohami H
Nihon Ronen Igakkai Zasshi; 1997 Jun; 34(6):461-7. PubMed ID: 9301260
[TBL] [Abstract][Full Text] [Related]
19. Proteoglycan-mediated inhibition of A beta proteolysis. A potential cause of senile plaque accumulation.
Gupta-Bansal R; Frederickson RC; Brunden KR
J Biol Chem; 1995 Aug; 270(31):18666-71. PubMed ID: 7629198
[TBL] [Abstract][Full Text] [Related]
20. Estradiol-stimulated turnover of heparan sulfate proteoglycan in mouse uterine epithelium.
Morris JE; Potter SW; Gaza-Bulseco G
J Biol Chem; 1988 Apr; 263(10):4712-8. PubMed ID: 2965148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
